Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone

Through its investment in PsyLabs, Psyence BioMed has secured: A licensed, owned, and debt-free production operation. Source-level ibogaine supply. Natural psilocybin supply. GMP-compliant ...

Mainz Biomed changes ticker symbol to QUCY

Mainz Biomed (QUCY), doing business as Quantum Cyber, has officially changed its ticker symbol to "QUCY" on the Nasdaq Capital Market. Further, the company’s name will change to Quantum Cyber N.V., ...
TMCnet

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Mr. Liscouski is a frequent contributor to CNBC, CNN, BBC, Fox News, and other business and security media on Homeland Security, Terrorism and Cyber Security issues and has appeared before Congress on ...
Zacks Investment Research on MSN

Orchestra BioMed Holdings, Inc. (OBIO) surpasses Q4 earnings and revenue estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of a loss of $0.38 per share. This compares to a loss of $0.43 per ...
Nasdaq

Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation Therapy to Address Uncontrolled Hypertension

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
U.S. News & World Report

Mainz Biomed N.V.

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is ...
Pharmabiz

China NMPA approves Harbour BioMed and Kelun-Biotech’s IND application for HBM7575/SKB575 to treat atopic dermatitis

Cambridge, Massachusetts Tuesday, March 10, 2026, 18:00 Hrs [IST] ...
The Business Journals

Texas Biomed wins designation that positions it for $100M in funding

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Heightened recognition and ...

BioMed Realty and CordenPharma Colorado Team Up for Expansion of Peptide Development Lab in New LEED(R) Gold-Certified Facility at Flatiron Park in Boulder

CordenPharma Colorado is leasing 5505 Central, a newly completed, purpose-built peptide development lab at Flatiron Park in Boulder (US). Photo credit: CordenPharma Photo ...
Business Wire

BioMed Realty Appoints Industry Veteran John Lee as Executive Vice President and Chief Operating Officer

SAN DIEGO--(BUSINESS WIRE)--BioMed Realty, a Blackstone portfolio company and leading provider of real estate solutions to the life science and technology industries, announced today that John Lee ...